International Patient | Medical Trip China

KNOWLEDGE HUB

Insights & Intelligence

Case studies, white papers, market intelligence and clinical trends — everything you need to understand the global medical tourism landscape and China's role in it.

SecondOpinion Support

Jul 1612 min read

Blog

Stem Cell Treatment in China for Canadian Patients: Real Costs, Regulatory Status & Safety Guide (2026)

ChinaCureLink

Jul 1311 min read

Blog

Stem Cell Treatment in China for Australian Patients: Costs, Process, and What to Verify Before You Travel

ChinaCureLink

Jul 1010 min read

Blog

Stem Cell Treatment in China for Saudi Arabian Patients: Costs, Process, and What to Verify Before You Travel

ChinaCureLink

Jul 314 min read

Blog

CAR-T Therapy in China for Saudi Arabia Patients: 7 Key Advantages to Consider in 2026

ChinaCureLink

Jun 2413 min read

Blog

Multiple Myeloma in China 2026: Domestic BCMA CAR-T Delivers 64% 12-Month PFS

ChinaCureLink

Apr 248 min read

Cases

Soft Tissue Sarcoma Treatment: 56-Year-Old Southeast Asian Patient Successfully Enrolled in Clinical Trial After Remote Consultation with National Cancer Center China

Insights & Intelligence

Stem Cell Treatment in China for Canadian Patients: Real Costs, Regulatory Status & Safety Guide (2026)

Stem Cell Treatment in China for Australian Patients: Costs, Process, and What to Verify Before You Travel

Stem Cell Treatment in China for Saudi Arabian Patients: Costs, Process, and What to Verify Before You Travel

CAR-T Therapy in China for Saudi Arabia Patients: 7 Key Advantages to Consider in 2026

Multiple Myeloma in China 2026: Domestic BCMA CAR-T Delivers 64% 12-Month PFS

Soft Tissue Sarcoma Treatment: 56-Year-Old Southeast Asian Patient Successfully Enrolled in Clinical Trial After Remote Consultation with National Cancer Center China

Stay Informed

Categories